跳至主要内容
临床试验/IRCT20170719035178N2
IRCT20170719035178N2招募中3 期

Investigating the efficacy of Ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy

Sabzevar University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 days 至 14 days(—)
性别
All

入选标准

  • Birth weight more than 2500 gr
  • Gestational age more than 37 weeks
  • The birthday more than 2 days and less than two weeks
  • The total bilirubin level is 14-20 mg/dl and the direct bilirubin level is less than 2 mg/dl
  • No Septicemia
  • lack of Crigler–Najjar syndrome
  • lack of Thyroid disease
  • lack of Liver disease
  • lack of direct hyperbilirubinemai
  • Incompatibility of blood groups and RH
  • lack of G6PD deficiency
  • Infants aged 2 to 14 days

排除标准

  • Parental dissatisfaction for any reason
  • The incidence of any side effects of Ursodeoxycholic acid
  • Infants from diabetic mother

研究者

发起方
Sabzevar University of Medical Sciences

相似试验